This is the third article in a series of alerts that addresses what businesses, organizations and governmental entities should be considering as they navigate privacy and cybersecurity challenges encountered in the transition to electric vehicles and the supporting infrastructure. Please find…
Source: www.jdsupra.com – Read more
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
